Aged CD8+ T cells circulating in blood release granzyme K (GZMK), a protein that directly impairs hippocampal function and cognitive performance without requiring immune cell infiltration into brain tissue. Using heterochronic parabiosis experiments, researchers demonstrated that exposing young mice to aged CD8+ T cells triggered synaptic changes and memory deficits, while targeting these cells or inhibiting GZMK rescued cognitive function in aged animals. This finding fundamentally reframes our understanding of immune-brain aging interactions. Rather than requiring physical immune invasion of neural tissue, circulating aged T cells appear to orchestrate cognitive decline through secreted factors that cross the blood-brain barrier. The identification of GZMK as a specific mediator provides an actionable therapeutic target, potentially more feasible than broad immunosuppression approaches. However, the translation from mouse models to human aging remains uncertain, particularly given species differences in immune system organization and blood-brain barrier permeability. This represents a paradigm shift toward viewing peripheral immune aging as a controllable driver of neurodegeneration, suggesting that immunomodulatory interventions targeting specific T cell populations could preserve cognitive function during aging.